Taking Israel from high tech to biotech

TEL AVIV - Israel's burgeoning biotech industry is beginning to attract more attention from its domestic finance community than ever before. The mission is to repeat the country's high tech miracle in the biotech sector. However, while international financers are lining up to invest in the Israeli lfe sciences research community, convincing local investors may take some time.

"Of the 80 or so Israeli venture capital firms currently in existence, with funds of about $2 billion, there are only about five to ten venture capitalists with a life sciences focus," said Yoav Millet, managing director of Zannex Capital Management (Israel) Ltd. (Ramat Gan)...